Report Feature
The future of the global molecular diagnostics market looks promising with opportunities in the infectious disease, oncology, and genetic test applications. The global molecular diagnostics market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic and infectious diseases, rising awareness of personalized medicines and companion diagnostics, and the growing biomarker identification market.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global molecular diagnostics market report, please download the report brochure.
In this market, reagents and kits is the largest product and service type of molecular diagnostics, whereas infectious diseases is the largest application. Growth in various segments of the molecular diagnostics market are given below:
The study includes trends and forecast for the global molecular diagnostics market by product and service, technology, application, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Reagents & Kits
- Instruments
- Services & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA (Deoxyribonucleic Acid) Sequencing & Next Generation Sequencing (NGS)
- In Situ Hybridization
- DNA Microarray
- Other Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Infectious Diseases
- Hepatitis
- HIV (Human Immunodeficiency Virus)
- CT/NG (Chlamydia Trachomatis)
- HAIs (Hospital Acquired Infections)
- HPV (Human Papillomavirus)
- Tuberculosis
- Influenza
- Other Infectious Diseases
-
Oncology
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
- Genetic Tests
- Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals & Academic Laboratories
- Reference Laboratories
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the molecular diagnostics companies profiled in this report include Roche, Qiagen, Hologic, Abbott Laboratories, Grifols, Siemens Healthcare, B&D, Beckman Coulter, bioMérieux, and Danaher.
Lucintel forecasts that reagents and kits will remain the largest product and service segment over the forecast period due to increasing research activities related to cancer and rising commercial applications.
Within this market, infectious diseases will remain the largest segment by application over the forecast period due to increasing hospital acquired infections.
Asia Pacific is expected to witness the highest growth over the forecast period due to rising disposable income, development of advanced healthcare infrastructure, and increasing penetration of cutting-edge clinical laboratory technologies in the region.
|
Features of the Global Molecular Diagnostics Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global molecular diagnostics market by product & service (reagents & kits, instruments, and services & software), technology (PCR, INAAT, DNA sequencing & (NGS, in situ hybridization, DNA microarray, and other technologies), application (infectious diseases (hepatitis, HIV, CT/NG, HAIs, HPV, tuberculosis, influenza, and other infectious diseases), oncology (breast cancer, colorectal cancer, lung cancer, prostate cancer, and other cancers), genetic tests, and others), end user (hospitals & academic laboratories, reference laboratories, and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global molecular diagnostics market? Q.5 What are the business risks and threats to the global molecular diagnostics market? Q.6 What are the emerging trends in this molecular diagnostics market and the reasons behind them? Q.7 What are some changing demands of customers in this molecular diagnostics market? Q.8 What are the new developments in this molecular diagnostics market? Which companies are leading these developments? Q.9 Who are the major players in this molecular diagnostics market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this molecular diagnostics market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global molecular diagnostics market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Service (Reagents & Kits, Instruments, and Services & Software), Technology (PCR, INAAT, DNA Sequencing & (NGS, In Situ Hybridization, DNA Microarray, and Other Technologies), Application (Infectious Diseases (Hepatitis, HIV, CT/NG, Hais, HPV, Tuberculosis, Influenza, and Other Infectious Diseases), Oncology (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers), Genetic Tests, and Others), End User (Hospitals & Academic Laboratories, Reference Laboratories, and Other End Users) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Molecular Diagnostics Market
4.1 Global Molecular Diagnostics Market by Region
4.2.1 Market by Product and Service: Reagents & Kits, Instruments, and Services & Software
4.2.2 Market by Technology: PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarray, and Other Technologies
4.2.3 Market by Application: Infectious Diseases (Hepatitis, HIV, CT/NG, HAIS, HPV, Tuberculosis, Influenza, and Other Infectious Diseases), Oncology (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers), Genetic Tests, and Others
4.2.4 Market by End User: Hospitals & Academic Laboratories, Reference Laboratories, and Other End Users
4.2.5 The United States Molecular Diagnostics Market
4.2.6 The Canadian Molecular Diagnostics Market
4.2.7 The Mexican Molecular Diagnostics Market
4.3.1 Market by Product and Service: Reagents & Kits, Instruments, and Services & Software
4.3.2 Market by Technology: PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarray, and Other Technologies
4.3.3 Market by Application: Infectious Diseases (Hepatitis, HIV, CT/NG, HAIS, HPV, Tuberculosis, Influenza, and Other Infectious Diseases), Oncology (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers), Genetic Tests, and Others
4.3.4 Market by End User: Hospitals & Academic Laboratories, Reference Laboratories, and Other End Users
4.3.5 The Molecular Diagnostics Market of United Kingdom
4.3.6 The German Molecular Diagnostics Market
4.3.7 The French Molecular Diagnostics Market
4.4.1 Market by Product and Service: Reagents & Kits, Instruments, and Services & Software
4.4.2 Market by Technology: PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarray, and Other Technologies
4.4.3 Market by Application: Infectious Diseases (Hepatitis, HIV, CT/NG, HAIS, HPV, Tuberculosis, Influenza, and Other Infectious Diseases), Oncology (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers), Genetic Tests, and Others
4.4.4 Market by End User: Hospitals & Academic Laboratories, Reference Laboratories, and Other End Users
4.4.5 The Chinese Molecular Diagnostics Market
4.4.6 The Indian Molecular Diagnostics Market
4.4.7 The Japanese Molecular Diagnostics Market
4.5.1 Market by Product and Service: Reagents & Kits, Instruments, and Services & Software
4.5.2 Market by Technology: PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarray, and Other Technologies
4.5.3 Market by Application: Infectious Diseases (Hepatitis, HIV, CT/NG, HAIS, HPV, Tuberculosis, Influenza, and Other Infectious Diseases), Oncology (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers), Genetic Tests, and Others
4.5.4 Market by End User: Hospitals & Academic Laboratories, Reference Laboratories, and Other End Users
4.5.5 Brazilian Molecular Diagnostics Market
7.1.1 Growth Opportunities for the Global Molecular Diagnostics Market by Product and Service
7.1.2 Growth Opportunities for the Global Molecular Diagnostics Market by Technology
7.1.3 Growth Opportunities for the Global Molecular Diagnostics Market by Application
7.1.4 Growth Opportunities for the Global Molecular Diagnostics Market by End User
7.1.5 Growth Opportunities for the Global Molecular Diagnostics Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
